Dataset Information

[Metabolomics Study on the Differences of Endogenous Small Molecule ?between A549/DDP and A549 Cells Based on High Solution UPLC-TOF-MS].

ABSTRACT: BACKGROUND:Cisplatin acquired resistance is a vital problem in the chemotherapy of non-small cell lung cancer, which needs to be further addressed. In recent years, obtaining drug resistant cells from cell cultivation and serving for metabolomics research to find differential metabolites and get potential biomarkers, is a good reference for clinical research and cancer treatment. This study aimed to obtain metabolite information related to cisplatin resistance through metabolomics analysis. METHODS:Metabolites were extracted from A549 cells and cisplatin resistant A549/DDP cells, and ultraperformance liquid chromatography coupled with time of flight mass spectrometry was used to perform metabolomic analysis of endogenous molecules of the two cells and obtain metabolic differences. RESULTS:Through data analysis, 40 metabolites were identified as differential metabolites, mainly involving phospholipids, fatty acids, amino acids and metabolites related to energy metabolism. CONCLUSIONS:The drug resistance of A549/DDP cells may be caused by the changes of cell membrane structure and related metabolic pathways.

SUBMITTER: Hong W

PROVIDER: S-EPMC6105355 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

[Metabolomics Study on the Differences of Endogenous Small Molecule  between A549/DDP and A549 Cells Based on High Solution UPLC-TOF-MS].

Hong Weipeng W Zhao Yonghua Y Cao Lin L Cao Di D Zhao Zhongxiang Z Jin Jing J

Zhongguo fei ai za zhi = Chinese journal of lung cancer 20180801 8

<h4>Background</h4>Cisplatin acquired resistance is a vital problem in the chemotherapy of non-small cell lung cancer, which needs to be further addressed. In recent years, obtaining drug resistant cells from cell cultivation and serving for metabolomics research to find differential metabolites and get potential biomarkers, is a good reference for clinical research and cancer treatment. This study aimed to obtain metabolite information related to cisplatin resistance through metabolomics analys ...[more]

PMID: 30172262

Similar Datasets

Project description:Hyperuricemia (HUA) as a metabolic disease is closely associated with metabolic disorders. The etiology and pathogenesis of HUA are not fully understood, so there is no radical cure so far. Metabolomics, a specialized study of endogenous small molecule substances, has become a powerful tool for metabolic pathway analysis of selected differential metabolites, which is helpful for initially revealing possible development mechanisms of various human diseases. Twenty HUA patients and 20 healthy individuals participated in the experiment, and ultrahigh performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF/MS) was employed to investigate serum samples to find differential metabolites. The statistical techniques used were principal component analysis and orthogonal partial least-squares discriminant analysis. The differences in metabolomics results of samples after pretreatment with different solvents were compared, 38, 20, 26, 28, 33, 50, and 40 potential differential metabolites were found, respectively, in HUA patient samples, and each group involved different metabolic pathways. Repetitive metabolites were removed, 138 differential metabolites in HUA serum were integrated for analysis, and the human body was affected by 7 metabolic pathways of glycerophospholipid metabolism, sphingolipid metabolism, arachidonic acid metabolism, linoleic acid metabolism, phenylalanine metabolism, phenylalanine, tyrosine and tryptophan biosynthesis, and α-linolenic acid metabolism. In this work, the metabolomics approach based on UPLC-Q-TOF/MS was employed to investigate serum metabolic changes in HUA patients, 138 potential differential metabolites related to HUA were identified, which provided associations of lipids, amino acids, fatty acids, organic acids, and nucleosides profiles of HUA individuals. Metabolic pathways involved in glycerophospholipid metabolism, sphingolipid metabolism, arachidonic acid metabolism, linoleic acid metabolism, phenylalanine metabolism, phenylalanine, tyrosine and tryptophan biosynthesis, and a-linolenic acid metabolism shed light on the understanding of the etiology and pathogenesis process of HUA.

Dataset Information

[Metabolomics Study on the Differences of Endogenous Small Molecule ?between A549/DDP and A549 Cells Based on High Solution UPLC-TOF-MS].

Publications

[Metabolomics Study on the Differences of Endogenous Small Molecule  between A549/DDP and A549 Cells Based on High Solution UPLC-TOF-MS].

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Dataset Information

[Metabolomics Study on the Differences of Endogenous Small Molecule ?between A549/DDP and A549 Cells Based on High Solution UPLC-TOF-MS].

Publications

[Metabolomics Study on the Differences of Endogenous Small Molecule between A549/DDP and A549 Cells Based on High Solution UPLC-TOF-MS].

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

[Metabolomics Study on the Differences of Endogenous Small Molecule  between A549/DDP and A549 Cells Based on High Solution UPLC-TOF-MS].